Pathway to Cures is a venture philanthropy fund that focuses on investing in innovative therapies and technologies aimed at finding cures. The firm typically participates in seed-stage investment rounds, with investments such as the $250,000 raised by Anvesana.

The firm is dedicated to supporting groundbreaking advancements in the medical field. Pathway to Cures offers strategic guidance and resources to its portfolio companies, leveraging its expertise and network to accelerate the development of transformative healthcare solutions.